Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01239680 · ClinicalTrials.gov registry record · NA
Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy
A NA study, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01239680: Completed NA study, sponsored by University of Missouri, Kansas City.
NCT01239680 is a NA study that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01239680, a NA study, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Overall aim of this work is to evaluate new methods of resuscitation that can be applied by front-line responders on the battlefield, in civilian life, or which can be used during initial resuscitation in the first fixed facility to which the injured patient is brought.
Primary Outcome
Biological response as characterized by selected cytokines, specifically tumor necrosis factor alpha (TNFα), interleukin one (IL-1β), and interleukin six (IL-6). These are measured using ELISA. Baseline values are expected to be either unobtainable, or in any case less than 50 picograms/ml. If there is a significant inflammatory response, values at 24 hours should be more than 100 picograms/ml for TNFα, IL-1β, and IL-6. Our hypothesis is that there will be a difference between study and control
Interventions
- DRUG Glutamine
- DRUG Ringer's Lactate
- DRUG Placebo (for Glutamine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01239680 record still lists
NCT01239680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Glutamine is the first listed.
NCT01239680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01239680 about?
NCT01239680 is a clinical study titled "Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy". Overall aim of this work is to evaluate new methods of resuscitation that can be applied by front-line responders on the battlefield, in civilian life, or which can be used during initial resuscitation in the first fixed facility to which the injured patient is brought.
What is the current status of trial NCT01239680?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01239680?
The interventions under investigation include: Glutamine (DRUG), Ringer's Lactate (DRUG), Placebo (for Glutamine) (DRUG).
Who is sponsoring clinical trial NCT01239680?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01239680's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia